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Recently, a complete characterization and detailed evaluation of the glycosaminoglycans of human milk were
performed. The total glycosaminoglycans content in milk from healthy mothers having delivered term or preterm
newborns showed a constant pattern which was essentially composed of two main polysaccharides: chondroitin
sulfate (60-70%) and heparin (30-40%). Moreover, considerable variations of glycosaminoglycans concentration were
found during the first month of lactation, the highest values being present in colostrum compared to mature milk.
Metabolism and potential biological functions of human milk glycosaminoglycans are hypothesized and future
studies are encouraged.Background
In the last few decades consistent evidence has been
reported on several human milk glycans (such as glyco-
proteins, glycolipids and especially oligosaccharides)
which have been demonstrated to possess specific bio-
logical properties, positively influencing the breastfed
newborn health [1-4]. On the contrary, only four studies
are actually available in the literature on another family
of complex carbohydrates, the glycosaminoglycans
(GAGs) [5-8].
GAGs are linear heteropolysaccharides composed of a
variable number of repeating disaccharidic units, which are
able to regulate many cellular events and physiological pro-
cesses (such as cell growth and differentiation, cell-cell and
cell-matrix interaction, anti-infective and anti-inflammatory
processes, etc.) [9-11]. On the basis of their structure and
composition, GAGs are generally grouped into four main
categories: 1) hyaluronic acid (HA); 2) chondroitin sulfates
(CS) and dermatan sulfate (DS); (3) heparan sulfate (HS)
and heparin (Hep); 4) keratan sulfate (KS).
State of the art
The first data reported in the literature on milk GAGs are
those described by Shimizu et al. [5]. Their study was not
performed on whole milk but exclusively focused on milk* Correspondence: g.v.coppa@univpm.it
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reproduction in any medium, provided the orfat globule membranes. The total GAG content was 5–10
times higher in human than in bovine milk membranes.
Qualitative analyses on membranes from mature milk
samples demonstrated that the major GAG in both bovine
and human milk was HS (70%), with the remainder 30%
represented by CS.
Further information on human milk GAG composition
was later provided by the study done by Newburg et al.
[6]. Even if no quantitative data were reported, it was
interestingly shown that GAGs isolated from human milk
were able to play an important role as anti-infective
agents.
Recently, a complete characterization and detailed
evaluation of the GAGs of human mature milk and
bovine milk were performed [7]. Great differences were
found between human and bovine milk in terms of both
quality and quantity (Table 1) (Figure 1). The total
amount of GAGs resulted about 7 times higher in
human milk compared to bovine milk. Moreover on the
basis of specific investigations, it was possible to precisely
define the composition of the complex mixture of GAGs
in human and bovine milks: CS, DS, Hep and HA were
identified in both milks. The main GAGs of human milk
were represented by CS (~55%) followed by Hep (~40%),
whose absolute amounts were ~23 and ~7 times respect-
ively higher than in bovine milk. On the other hand, the
main bovine milk GAG was DS (~40%) followed by Hep
(~30%) and CS (~21%).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 GAGs quantitative evaluation in human and
bovine milk
Human milk Bovine milk
Total GAGs (mg/L) 416.2 60.2
GAGs (mg/L) GAGs (mg/L)
Chondroitin Sulfate 231 13
Dermatan Sulfate 7 24
Heparin 173 21

























Figure 2 Content of GAGs in term and preterm human milk
during the first month of lactation.
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from healthy mothers having delivered term or preterm
newborns was evaluated during the first month of lactation
[8]. In both term and preterm milk, GAGs showed a con-
stant pattern which was essentially composed of two main
polysaccharides: CS (60-70%) and Hep (30-40%). Moreover,
considerable variations of GAG concentration were found
during the period studied. In fact, highest values were
present at 4th day (9.3 and 3.8 g/L in preterm and term
milk respectively), followed by a progressive decrease up to
30th day (4.3 and 0.4 g/L) (Figure 2).
Metabolism and potential biological functions
In the alveolar cells of the mammary gland, the synthetized














Figure 1 Percentage distribution of GAGs in human and bovine
milk.excreted into the glandular ductus as the macromolecular
complex of Proteoglycans (PGs) (Figure 3a and b). From
the above reported results, it follows that breastfed infants
ingest consistent daily amounts of GAGs (as PGs). How-
ever, at present, no data are available on their metabolic
fate.
It seems reasonable to hypothesize (Figure 4) that at the
small intestine level the proteolytic enzymes secreted in the
pancreatic juice digest the “core” protein of PGs into
aminoacids, which are absorbed, resulting in the liberation
of free GAG chains. As the intestinal wall and microvilli
lack specific glycosidases and sulfatases, the free GAGs
should persist undegraded in the upper part of the digestive
system [12]. Recent studies provide further demonstration
of the physiological role of GAGs in several biological
processes [9,11]. In particular, it has been shown that some
cell surface receptors are constituted by GAGs [11], partici-
pating directly, in this way, in the regulation of the infective
processes. Therefore, human milk GAGs could have the
power to interact with pathogens and to compete for
their adhesion to the intestinal wall, as already demon-
strated for other human milk glycans [1,2,13]. In fact,
the first data available on the anti-infective role of
human milk GAGs are those reported by Newburg et al.
[6]. Detailed analyses performed on isolated GAGs
demonstrate the presence of a complex mixture made
up of DS, Hep, HS and CS. For the first time, these
authors demonstrated that CS isolated from human
milk was able to inhibit the binding of the HIV envelop
glycoprotein gp120 to the cellular CD4 receptor. More-
over, it was recently demonstrated that HA fragments
play an important role in promoting an innate anti-
microbial effect in intestinal epithelial cells [14]. On the
basis of these data we can suppose that the high concen-
tration of human milk GAGs could be useful for the
newborn in defence processes against several pathogens
(viruses, bacteria and their toxins).
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Figure 3 Synthesis (a) and structure (b) of a proteoglycan.
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Figure 4 Hypothetic metabolic fate and biological functions of human milk GAGs.
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their well-known properties, could contribute to the
antioxidant effect of human milk, which is particularly
important during the neonatal period. In fact, it has been
demonstrated that CS (and other GAGs) are able to
stimulate the pathway which induces the activation of
antioxidant enzymes [15], and which is particularly
important in preterm infants endowed with an immature
defence system.
Furthermore, the undigested GAGs, reaching the
colon, could behave as prebiotics, contributing to the
development of bifidogenic flora as it has been demon-
strated that bifidobacteria possess specific enzymes
involved in the metabolism of carbohydrates [16].
Finally, a certain amount of undigested GAGs could be
present in infant feces behaving as dietary fibers according
to international definition.
Future perspectives
From the review of the literature, it clearly emerges that
further studies are necessary to explore the metabolic fate,
the physiological role and other human milk GAGs possible
positive effects on the newborn’s health. As for other glycan
components such as oligosaccharides, further in vitro and
in vivo studies should be performed to achieve more
information on their possible antinfective, antioxidant and
prebiotic effects.
Finally, new knowledge on human milk components is
the starting basis for the preparation of improved infant
formulas in the future.
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